Because of this, TRT can cause hemoglobin and hematocrit to rise, sometimes to levels that need medical attention. These blood markers are a key part of long-term safety, and understanding them is essential for anyone using testosterone therapy. In particular, TRT often changes levels of hemoglobin and hematocrit. These cells also have increased chemokine production and exhibit "N2-like" phenotypes, which decrease their ability to kill bacteria. You may be surprised to learn that it can increase your hematocrit and neutrophil count. Changes from baseline in total and differential leukocyte count, and platelet count were evaluated. In 5aR trial, 102 healthy men, years (mean age 38), received a long-acting GnRH agonist, and 50, 125, 300, or 600 mg/week testosterone enanthate (TE) plus placebo or 2.5 mg/ day dutasteride for 20 weeks. Glaxo-SmithKline Inc provided dutasteride and placebo and ENDO Pharmaceuticals provided testosterone enanthate. Safety and therapeutic implications of these findings, and the molecular mechanisms by which testosterone regulates the differentiation of hematopoietic progenitors need further investigation. These findings also have therapeutic implications for the potential use of testosterone to treat some types of myelodysplastic conditions and cytopenias. But like any medical treatment, it also requires regular monitoring to stay safe. One person may see a mild rise in hemoglobin, while another may see a rapid increase. Proper hydration helps your blood stay at a normal thickness. Combining smoking and TRT increases the risk even more. Intramuscular injectionsInjections, especially long-acting ones, are the form most likely to raise hemoglobin. Some research even finds rates as high as 30%, depending on the testosterone dose and how it is given. This does not mean TRT always causes dangerously high hemoglobin. TRT often raises testosterone much higher, especially right after injections. RNA samples were prepared using a QIAcube with the PAXgene blood RNA kit (Qiagen) and analysed using the Nanostring nCounter Sprint Profiler system with a broad human immune response panel (Human Immunology v.2 Gene Expression CodeSet) as described previously6. A blood sample obtained from a healthy female donor was mixed in equal ratio with WB-STIM buffer (Cytodelics AB) without phenol red. Next, the cells were stained with a cocktail of antibodies targeting intracellular antigens (Supplementary Table 4) for 30 min at 4 °C and then acquired using an Aurora spectral cytometer. Horizon Brilliant Stain Buffer Plus was added, and the cells were stained with a cocktail of fluorochrome conjugated antibodies targeting surface antigens for 30 min at 4 °C (Supplementary Table 4). Phlebotomy and low-dose aspirin are treatments for polycythemia vera. Danger mainly arises when the cause is polycythemia vera (PV) or, very rarely, when the hematocrit becomes extremely high in certain congenital heart or lung conditions. For most people, polycythemia is not dangerous, especially when it is due to common, reversible, or physiologic reasons. In secondary or relative polycythemia, symptoms usually come from the underlying condition, not the elevated hemoglobin itself. Using a CPAP machine or getting treatment can greatly reduce your risk. Sleep apnea is one of the biggest risk factors for high hemoglobin on TRT. There are many ways to reduce risks while continuing therapy. While some people feel normal even if their hemoglobin rises, others may feel symptoms. Most people can stay safely on TRT as long as they check their labs and follow the treatment plan. When these levels get too high, the blood becomes thicker. However, hematocrit concentrations were higher in men than women in both age groups. Additionally, testosterone inhibits the production of antibodies by B lymphocytes. In the presence of LPS, testosterone-treated neutrophils showed increased numbers of intracinar neutrophils. In this study, rats were orchidectomized and treated with two to ten mg/kg/day of testosterone for 7 days. Another study in rats found that testosterone impairs neutrophils' ability to kill bacteria. Several studies have demonstrated that testosterone can increase the number of neutrophils in vivo. This article is not intended to be a medical reference, but a guide to help you decide whether or not testosterone is right for you.
